Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Publication

Publications

Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice

Title
Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Type
Article in International Scientific Journal
Year
2015
Authors
Pinheiro Costa, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, JM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Beato, JN
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Freitas da Costa, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Brandao, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Manuel Falcão
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Falcão-Reis F
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Ângela Carneiro
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Title: OphthalmologicaImported from Authenticus Search for Journal Publications
Vol. 233
Pages: 155-161
ISSN: 0030-3755
Publisher: Karger
Other information
Authenticus ID: P-00G-BHZ
Abstract (EN): Purpose: To report the clinical outcomes of intravitreal aflibercept therapy in eyes with refractory and recurrent neovascular age-related macular degeneration (AMD) switched from intravitreal bevacizumab or ranibizunnab. Methods: This is a retrospective review of eyes with neovascular AMD switched to intravitreal aflibercept with at least 1 year of follow-up after the switch. All patients had had a minimum of 3 injections of bevacizumab or ranibizumab before the switch. Aflibercept was used in patients considered refractory to bevacizumab (group 1) and in recurrent patients on therapy with ranibizumab due to an institutional policy decision (group 2). Changes in best-corrected visual acuity, fluid on optical coherence tomography (OCT), central retinal thickness (CRT) and the frequency of injections were compared. Results: Eighty-five eyes of 69 patients were analyzed, 39 eyes in group 1 and 46 in group 2. The mean follow-up time was 31.6 months prior to the switch and 14.7 months on treatment with aflibercept. One year after the switch, there was a nonsignificant mean decrease of 2 letters in visual acuity in both groups (group 1: from 58.2 to 55.8 letters, p = 0.086; group 2: from 56.4 to 54.5 letters, p = 0.168), but the mean number of injections per month was significantly lower (from 0.76 to 0.57, p<0.001). With the switch, 90.6% of the patients showed anatomic improvement with a reduction of fluid on OCT, and both groups presented significant improvement in CRT (group 1: 65.3 mu m, p = 0.051; group 2: 91.0 mu m, p < 0.001). Conclusion: Aflibercept appears to be a valuable tool for the management of patients with poor responses to other anti-vascular endothelial growth factor drugs. These patients could have anatomic improvement, and the injection intervals could be extended. (C) 2015 S. Karger AG, Basel
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The Impact of COVID-19 Pandemic on Surgical Primary Retinal Detachments (2022)
Article in International Scientific Journal
Ferreira, A; Afonso, M; Silva, N; Meireles, A
Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison (2014)
Article in International Scientific Journal
Pinheiro Costa, J; Freitas da Costa, P; Manuel Falcão; Brandao, EM; Falcão-Reis F; Ângela Carneiro
Screening for Diabetic Retinopathy Using an Automated Diagnostic System Based on Deep Learning: Diagnostic Accuracy Assessment (2021)
Article in International Scientific Journal
Rego, S; Dutra Medeiros, M; Soares, F; Matilde Soares
Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia (2011)
Article in International Scientific Journal
Ângela Carneiro; Silva, RM; Veludo, MJ; Barbosa, A; Ruiz Moreno, JM; Manuel Falcão; Brandao, EM; Falcão-Reis F
Quantitative Optical Coherence Tomography Angiography Biomarkers for Alport Syndrome (2022)
Article in International Scientific Journal
Ana Cunha; Teixeira, D; Cabral, D; Estrela-Silva, S; Falcao-Reis, F; Ângela Carneiro

See all (14)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-24 at 00:55:29 | Privacy Policy | Personal Data Protection Policy | Whistleblowing